0001438133-20-000139.txt : 20200904 0001438133-20-000139.hdr.sgml : 20200904 20200904164353 ACCESSION NUMBER: 0001438133-20-000139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200903 FILED AS OF DATE: 20200904 DATE AS OF CHANGE: 20200904 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HANSEN BRIAN B CENTRAL INDEX KEY: 0001542377 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36189 FILM NUMBER: 201162216 MAIL ADDRESS: STREET 1: 10210 GENETIC CENTER DRIVE CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TANDEM DIABETES CARE INC CENTRAL INDEX KEY: 0001438133 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204327508 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 BUSINESS PHONE: 858-366-6900 MAIL ADDRESS: STREET 1: 11075 ROSELLE STREET CITY: San Diego STATE: CA ZIP: 92121 4 1 wf-form4_159925221488378.xml FORM 4 X0306 4 2020-09-03 0 0001438133 TANDEM DIABETES CARE INC TNDM 0001542377 HANSEN BRIAN B 11075 ROSELLE ST SAN DIEGO CA 92121 0 1 0 0 EVP & CHIEF COMMERCIAL OFFICER Common Stock 2020-09-03 4 M 0 9146 69.50 A 13811 D Common Stock 2020-09-03 4 M 0 25000 18.86 A 38811 D Common Stock 2020-09-03 4 S 0 10215 110.3238 D 28596 D Common Stock 2020-09-03 4 S 0 23731 111.4766 D 4865 D Common Stock 2020-09-03 4 S 0 200 112.18 D 4665 D Common Stock 2020-09-03 4 M 0 4986 51.50 A 9651 D Common Stock 2020-09-03 4 S 0 4986 112.8879 D 4665 D Stock Option 69.5 2020-09-03 4 M 0 9146 0 D Common Stock 9146.0 0 D Stock Option 18.86 2020-09-03 4 M 0 25000 0 D Common Stock 25000.0 0 D Stock Option 51.5 2020-09-03 4 M 0 4986 0 D Common Stock 4986.0 100014 D Represents shares of common stock received upon exercise of a stock option award. The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 4, 2020. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $109.78 and $110.76.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $110.78 and $111.72.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $112.18 and $112.19.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $112.75 and $113.42.The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. The option vested as to twenty-five percent (25%) of the underlying shares on 12/16/2017, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter. The expiration date for these options is 10 years from the date of grant. The option vested as to fifty percent (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter. The option vested as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. s/ David B. Berger, Attorney-in-Fact for Brian B. Hansen 2020-09-04